Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in SGMT — Sagimet Biosciences Inc.

CIK 1446194 BALA CYNWYD, PA

Position in SGMT

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$651,055
-$408,767 QoQ
Shares Held
124,604
-30.4% QoQ
Ownership
0.202%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SGMT Over Time

Shares Held

Position Value (USD)

Derivatives in SGMT

reported options exposure · as of Mar 31, 2026
CallValue
$579,975
CallShares
111,000
PutValue
$456,665
PutShares
87,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,162,367,415 across 355 Biotechnology names. SGMT ranks #209 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SGMT

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $651,055 124,604
2026-03-31 $579,975 111,000
2026-03-31 $456,665 87,400
2025-12-31 $203,056 34,300
2025-12-31 $1,059,822 179,024
2025-12-31 $334,480 56,500
2025-09-30 $444,528 64,800
2025-09-30 $1,110,634 161,900
2025-09-30 $223,368 32,561
2025-06-30 $592,836 77,800
2025-06-30 $1,077,520 141,407
2025-06-30 $1,147,572 150,600
2025-03-31 $217,768 66,800
2025-03-31 $610,747 187,346
2025-03-31 $181,908 55,800
2024-12-31 $771,300 171,400
2024-12-31 $809,397 179,866
2024-12-31 $100,800 22,400
2024-09-30 $252,070 91,000
2024-09-30 $440,249 158,935
2024-06-30 $345,638 101,064
2024-03-31 $151,342 27,923